Trial · NCT07494552
Running Environments on Physiological Responses, Emotion, Motivation, and Attention
NCT07494552, Not applicable, Completed, Shanghai University of Sport
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Running Environments on Physiological Responses, Emotion, Motivation, and Attention. Trials, record NCT07494552. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07494552
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Running Environments on Physiological Responses, Emotion, Motivation, and Attention
- NCT number
- NCT07494552
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 29 participants, actual
- Lead sponsor
- Shanghai University of Sport
- Conditions
- Sport Participation
- Interventions
- Indoor Treadmill Running Session, Outdoor Road Running Session, Outdoor Grass Running Session
- First posted
- 2026-03-27
- Last updated
- 2026-07-21
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Salivary Cortisol Concentration | Baseline (pre-exercise) and 20 minutes post-exercise. | Salivary cortisol concentration will be measured to evaluate the acute endocrine and physiological stress response to different running environments. |
| Secondary | Change in Heart Rate Variability (HRV) | Baseline (pre-exercise), immediately post-exercise, 5 minutes post-exercise, 10 minutes post-exercise, and 20 minutes post-exercise. | Heart Rate Variability (HRV) parameters, specifically RMSSD and SDNN, will be recorded to assess the acute autonomic nervous system responses and recovery. Both parameters share the exact same unit of measure, which is milliseconds (ms). |
| Secondary | Change in Systolic and Diastolic Blood Pressure | Baseline (pre-exercise), immediately post-exercise, 5 minutes post-exercise, 10 minutes post-exercise, and 20 minutes post-exercise. | Blood pressure will be measured in mmHg to evaluate the cardiovascular stress response across different running environments. |
| Secondary | Change in Blood Lactate Concentration | Baseline (pre-exercise) and immediately post-exercise. | Blood lactate will be measured using a portable analyzer to assess metabolic exertion. |
| Secondary | Inhibitory Control Assessed by the Stroop Task: Reaction Time | Baseline (pre-exercise) and 20 minutes post-exercise. | The Stroop task measures inhibitory control and cognitive interference. This measure reports the reaction time in milliseconds (ms). Lower reaction times indicate better inhibitory control. |
| Secondary | Response Inhibition Assessed by the Go/No-Go Task: Reaction Time | Baseline (pre-exercise) and 20 minutes post-exercise. | The Go/No-Go task is used to evaluate response inhibition and impulse control. This measure reports the reaction time in milliseconds (ms) for "Go" trials. Lower values indicate faster processing speed. |
| Secondary | Change in Heart Rate | Baseline (pre-exercise), immediately post-exercise, 5 minutes post-exercise, 10 minutes post-exercise, and 20 minutes post-exercise. | Heart rate will be monitored and recorded in beats per minute (bpm) to assess cardiovascular exertion during the intervention and the subsequent recovery rate. |
| Secondary | Mood State Assessed by Positive and Negative Affect Schedule (PANAS) | Baseline (pre-exercise) and 20 minutes post-exercise. | The Positive and Negative Affect Schedule (PANAS) consists of two subscales to measure both positive affect (10 items) and negative affect (10 items) reflecting the past week. Items are rated on a 5-point scale. For the Positive Affect subscale, the minimum possible score is 10 and the maximum possible score is 50, with higher scores indicating higher levels of positive emotions (a better outcome). For the Negative Affect subscale, the minimum possible score is 10 and the maximum possible score is 50, with higher scores indicating higher levels of negative emotions (a worse outcome). |
| Secondary | Change in Exercise Enjoyment Assessed by Physical Activity Enjoyment Scale (PACES) | Baseline (pre-exercise) and 20 minutes post-exercise. | The Physical Activity Enjoyment Scale (PACES) is used to evaluate the participant's subjective enjoyment of the exercise session. The scale consists of 18 items, each rated on a 7-point scale (1=completely disagree, 7=completely agree). The total score ranges from 18 to 126. Higher scores indicate a greater level of exercise enjoyment (a better outcome). |
| Secondary | Habitual Sport Motivation Assessed by Sport Motivation Scale (SMS) | Baseline (pre-exercise) and 20 minutes post-exercise. | The Sport Motivation Scale (SMS) is used to evaluate habitual, long-term motivation toward sports (reflecting on the past year). It consists of 28 items rated on a 7-point scale (1=does not correspond at all, 7=corresponds exactly). The total global score ranges from 28 to 196. Higher scores indicate higher levels of self-determined motivation toward sports (a better outcome). |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Go/No-Go Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07494552
GET https://conductscience.org/api/trials/v1/NCT07494552/registered